| scholarly article | Q13442814 |
| P50 | author | Qasim Aziz | Q77522324 |
| P2093 | author name string | Adam D Farmer | |
| P2860 | cites work | The capsaicin receptor: a heat-activated ion channel in the pain pathway | Q24322558 |
| Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms | Q28265946 | ||
| TRP channels: targets for the relief of pain | Q28290040 | ||
| Spinal and supraspinal modulation of visceral sensation | Q30542451 | ||
| Brain imaging and functional gastrointestinal disorders: has it helped our understanding? | Q30942661 | ||
| New technologies to investigate the brain-gut axis. | Q33398614 | ||
| Irritable bowel syndrome aggregates strongly in families: a family-based case-control study | Q33862306 | ||
| Pharmacokinetics of the TRPV1 antagonist ABT-102 in healthy human volunteers: population analysis of data from 3 phase 1 trials | Q33897649 | ||
| Protease-activated receptors in inflammation, neuronal signaling and pain | Q34175474 | ||
| U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact | Q34353536 | ||
| Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats | Q34421388 | ||
| Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. | Q34423405 | ||
| Guidelines on the irritable bowel syndrome: mechanisms and practical management. | Q34626602 | ||
| New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models. | Q34648477 | ||
| The role of experimental models in developing new treatments for irritable bowel syndrome | Q35071310 | ||
| The role of psychological and biological factors in postinfective gut dysfunction | Q35354188 | ||
| Laser Doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease | Q35359068 | ||
| Sex specific alterations in autonomic function among patients with irritable bowel syndrome | Q35597781 | ||
| Modulation of visceral pain and inflammation by protease-activated receptors | Q35722704 | ||
| Visceral pain: the ins and outs, the ups and downs | Q35738047 | ||
| Irritable bowel syndrome in the general population | Q35819583 | ||
| Definition and epidemiology of functional gastrointestinal disorders | Q35868634 | ||
| TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia | Q35908550 | ||
| Long-term colonic hypersensitivity in adult rats induced by neonatal unpredictable vs predictable shock | Q35971425 | ||
| What does the future hold for irritable bowel syndrome and the functional gastrointestinal disorders? | Q36083892 | ||
| Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments | Q36111350 | ||
| Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. | Q36371606 | ||
| Fundamentals of neurogastroenterology: basic science | Q36470080 | ||
| Mechanisms of disease: pain in fibromyalgia syndrome | Q36577418 | ||
| Abuse in women and men with and without functional gastrointestinal disorders. | Q36700073 | ||
| Protease activated receptors: clinical relevance to hemostasis and inflammation | Q36720123 | ||
| Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients | Q60679777 | ||
| Splanchnic and pelvic mechanosensory afferents signal different qualities of colonic stimuli in mice | Q60730314 | ||
| The irritable bowel syndrome | Q70221960 | ||
| Symptom complaints and health care seeking behavior in subjects with bowel dysfunction | Q71391621 | ||
| Medical costs in community subjects with irritable bowel syndrome | Q71584338 | ||
| Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities | Q72330659 | ||
| Autonomic nervous system function in women with irritable bowel syndrome | Q74049510 | ||
| Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds | Q74262429 | ||
| Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients: a hospital-based Oriental study | Q77181023 | ||
| Different autonomic responses to experimental pain in IBS patients and healthy controls | Q79175490 | ||
| The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats | Q79676503 | ||
| Vagal dysfunction in irritable bowel syndrome assessed by rectal distension and baroreceptor sensitivity | Q80457625 | ||
| New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. | Q36724324 | ||
| Selective role for TRPV4 ion channels in visceral sensory pathways. | Q36823423 | ||
| Relationship of abuse history to functional gastrointestinal disorders and symptoms: some possible mediating mechanisms | Q36862809 | ||
| Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain | Q36930795 | ||
| Postinflammatory visceral sensitivity and pain mechanisms | Q37134549 | ||
| Peripheral corticotropin releasing hormone mediates post-inflammatory visceral hypersensitivity in rats | Q37196875 | ||
| Recent progress in the development of selective TRPV1 antagonists for pain. | Q37320551 | ||
| Basic and clinical aspects of gastrointestinal pain | Q37372977 | ||
| Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents | Q37506609 | ||
| TRP channels: new targets for visceral pain | Q37653083 | ||
| Unbalanced expression of protease-activated receptors-1 and -2 in the colon of diarrhea-predominant irritable bowel syndrome patients | Q39980879 | ||
| Genetics of irritable bowel syndrome | Q40062485 | ||
| Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms | Q42437606 | ||
| Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome | Q43250132 | ||
| Epidemiology of colonic symptoms and the irritable bowel syndrome | Q43311739 | ||
| Nociception attenuates parasympathetic but not sympathetic baroreflex via NK1 receptors in the rat nucleus tractus solitarii | Q44482219 | ||
| The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor | Q44779669 | ||
| The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates | Q45048709 | ||
| Pain perception in irritable bowel syndrome. | Q45957186 | ||
| Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia | Q46090516 | ||
| Amitriptyline modifies the visceral hypersensitivity response to acute stress in the irritable bowel syndrome | Q46201082 | ||
| TRPA1 in bradykinin-induced mechanical hypersensitivity of vagal C fibers in guinea pig esophagus | Q46228820 | ||
| Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats | Q46325802 | ||
| The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. | Q46818690 | ||
| HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain | Q46833866 | ||
| Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? | Q46939907 | ||
| Dysfunction of the autonomic nervous system activity is responsible for gastric myoelectric disturbances in the irritable bowel syndrome patients | Q46977156 | ||
| The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans | Q47566218 | ||
| Contribution of central sensitisation to the development of non-cardiac chest pain | Q47586539 | ||
| Development of esophageal hypersensitivity following experimental duodenal acidification. | Q47635916 | ||
| Autonomic cardiovascular responses are impaired in women with irritable bowel syndrome | Q47939257 | ||
| Visceral pain readouts in experimental medicine. | Q48381500 | ||
| Role of the right vagal nerve trunk in antinociception | Q48681554 | ||
| Effects of attention on visceral stimulus intensity encoding in the male human brain. | Q48886579 | ||
| Corticotropin-releasing factor induces rectal hypersensitivity after repetitive painful rectal distention in healthy humans | Q48925989 | ||
| Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome | Q49117022 | ||
| The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects | Q50171831 | ||
| Incidence of a clinical diagnosis of the irritable bowel syndrome in a United States population. | Q50743522 | ||
| Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients. | Q50879482 | ||
| Evidence for autonomic dysregulation in the irritable bowel syndrome. | Q51040780 | ||
| A psychophysiological study in humans using phasic colonic distension as a noxious visceral stimulus. | Q51722601 | ||
| Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity. | Q52600188 | ||
| Altered rectal perception is a biological marker of patients with irritable bowel syndrome. | Q53641269 | ||
| Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome | Q56996391 | ||
| The Hot Mustard Receptor's Role in Gut Motor Function | Q57778675 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 39-47 | |
| P577 | publication date | 2013-02-01 | |
| P1433 | published in | British Journal of Pain | Q27725960 |
| P1476 | title | Gut pain & visceral hypersensitivity | |
| P478 | volume | 7 |
| Q33796978 | Brain functional connectivity is associated with visceral sensitivity in women with Irritable Bowel Syndrome. |
| Q64985481 | Do MicroRNAs Modulate Visceral Pain? |
| Q41562546 | Early-life adversity, epigenetics, and visceral hypersensitivity |
| Q35053636 | Effects of dominant/subordinate social status on formalin-induced pain and changes in serum proinflammatory cytokine concentrations in mice |
| Q47245994 | Motor, Somatosensory, Viscerosensory and Metabolic Impairments in a Heterozygous Female Rat Model of Rett Syndrome |
| Q89013977 | NaV1.1 inhibition can reduce visceral hypersensitivity |
| Q42013293 | Pharmacological evaluation of NSAID-induced gastropathy as a "Translatable" model of referred visceral hypersensitivity |
| Q35430526 | Role of principal ionotropic and metabotropic receptors in visceral pain |
| Q35087100 | Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities |
| Q38424879 | The head says yes but the heart says no: what is non-cardiac chest pain and how is it managed? |
Search more.